Caina Technology Co

Caina Technology Co Rule of 40

The Rule of 40 of Caina Technology Co (301122.SZ) as of Oct 30, 2026 is -7.14 %. In the previous year, Rule of 40 was 9.31 % — a change of -176.68% (lower).

Rule of 40

-7.14 %

YoY

-176.68%

Last updated:

Rule of 40 of Caina Technology Co is 2025 -7.14 % . Rule of 40 of Caina Technology Co was 2024 9.31 % . It decreases by -176.68% lower compared to the previous year.

The Caina Technology Co Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2018
69.38 CNY
Jan 1, 2019
48.88 CNY
Jan 1, 2020
210.77 CNY
Jan 1, 2021
21.89 CNY
Jan 1, 2022
43.94 CNY
Jan 1, 2023
19.73 CNY
Jan 1, 2024
9.31 CNY
Jan 1, 2025
-7.14 CNY
The Caina Technology Co Rule of 40 history
YEARRule of 40YoY
-7.14 %-176.68%
9.31 %-52.79%
19.73 %-55.10%
43.94 %+100.76%
21.89 %-89.62%
210.77 %+331.22%
48.88 %-29.55%
69.38 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Caina Technology Co Stock analysis

What does Caina Technology Co do? Caina Technology Co., Ltd. manufactures medical consumables including puncture needles, syringes, laboratory consumables, and masks. The company's main products are reusable copper base injection needles, aluminum base injection needles, disposable aluminum-plastic inlaid injection needles, safety blood collection needles, sheathed syringes, disposable Sterile syringes, petri dishes, and reagent tubes. Caina Technology exports its products to the United States, the United Kingdom, and the European Union, serving international markets with its medical supplies. The company generates revenue through the sale of its medical consumables to global healthcare providers and distributors. Its product range targets hospitals, clinics, and laboratories requiring reliable medical equipment. Caina Technology's focus on exporting to developed markets ensures steady demand for its high-quality, compliant medical products. Caina Technology's business model relies on manufacturing and exporting medical consumables to international customers. The firm's product portfolio includes specialized items like safety blood collection needles and sterile syringes, which are essential for healthcare facilities. By targeting key regions such as the United States, United Kingdom, and European Union, the company secures consistent sales channels for its medical supplies. Caina Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Caina Technology Co stock

Rule of 40 of Caina Technology Co is -7.14 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 Caina Technology Co since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Caina Technology Co

All Key Metrics — Caina Technology Co